Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum
about
Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and miceHuman brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function.Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c miceRecombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 typeOral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308Effects of cytokines on intracellular growth of Brucella abortus.Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.Immunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approachA B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.Cell response to a salt-extractable and sonicated Brucella melitensis 16M antigen in human brucellosis.Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosisImmune Response of Calves Vaccinated with Brucella abortus S19 or RB51 and Revaccinated with RB51Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccinesOverexpression of Brucella putative glycosyltransferase WbkA in B. abortus RB51 leads to production of exopolysaccharide.Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation usedWhat have we learned from brucellosis in the mouse model?Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in miceConstruction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in miceSurvival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.
P2860
Q31968527-0137CD52-5469-4703-8A22-E400CC27D4F9Q33596260-529418AE-A781-4FF3-AD63-66C46FCA9DCCQ33937494-F401CEFE-7D6F-43D0-ABAA-E80F310F411EQ33963052-92365649-AB1D-4134-9534-44D8ECF8A6FFQ33998168-6E38E37C-4735-4130-9857-B75CFD1F7C3EQ34004642-9934421C-3C77-405D-9A3C-20051E17448AQ34004646-18CFEDDB-61E1-49E0-A6E4-889E9317AB8FQ34008913-530173D5-8350-4F7F-A83F-31513FD52F32Q34121062-ACEE38C5-8F6B-42F1-A508-80377D57C871Q34121084-72E57BA9-F887-4289-8E05-E1D1E674EA1DQ34199069-8ED5C206-0638-4059-B228-DAED95FFB707Q34521159-D0F29CFE-7756-4353-AA13-A952F6121C72Q34544752-A388CB2A-11E3-4BC7-9416-6ED05A27E732Q34637943-E189FEAB-7398-45C8-80E3-55C1EC849554Q35133901-BDAD4921-5FDE-404B-BD58-3F52A458F0B5Q35224560-4C1CCD6D-36EB-4AAD-8C6A-7B7B22825E80Q35380623-640177D6-E65A-49A3-A7CB-C6053886ECFAQ35432482-B83F9ADE-2040-4EB8-8A1C-C20AA9C72C97Q35503256-CFA734F2-E9A1-43AA-9D16-A63CF36F3A0CQ35767656-8521F7A1-7B2E-43EA-8ECF-9F8A1BBCD690Q35773419-94E5FC3A-D98E-4972-8D99-EE489DC4F0ACQ35773649-A7CBA1C5-E45C-46A8-8703-097589119699Q36045879-34F557FB-DA9F-4B70-89A6-35470E96CE62Q36136716-81A409C7-1C91-41E9-B1CC-8281BF6C7946Q36228814-490D8B6E-D6E9-4A53-9DD3-3EC8A4349EA2Q36947807-78192ADA-162B-4602-BB67-638F54B296A1Q36948267-1AF8BEBE-F072-466E-9076-AF42FF10C276Q38037536-4781363A-7842-41AB-A671-FD76843C27D3Q39461733-5E815775-4F13-4E95-97EB-FB764EE48927Q41761576-5ADA4225-9665-441C-9B95-2F201DD5B682
P2860
Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Comparative protection of mice ...... fer of immune T cells or serum
@en
type
label
Comparative protection of mice ...... fer of immune T cells or serum
@en
prefLabel
Comparative protection of mice ...... fer of immune T cells or serum
@en
P2860
P1476
Comparative protection of mice ...... fer of immune T cells or serum
@en
P2093
P2860
P304
P407
P577
1990-01-01T00:00:00Z